Focused scientific advisory
Services built around the decisions that move programs forward.
Flexible engagements for biotechnology companies, investors, and research organizations—from focused assessments to ongoing strategic support.
Build the right evidence
Preclinical Strategy & NAMs Integration
Design translational preclinical strategies that align disease biology, experimental workflows, and human-relevant models with development milestones.
Where we focus
- Translational preclinical strategy
- Disease model selection
- Organoid and organ-on-chip implementation
- Experimental and assay design
- CRO and platform evaluation
- Target validation strategy
What you receive
- Integrated scientific roadmap
- Model and platform recommendations
- Fit-for-purpose validation plan
- Prioritized experimental strategy
Translate complex signals
Biomedical Data Analytics
Integrate biological, clinical, and real-world data to generate actionable insights that support target validation, disease understanding, and critical R&D decisions.
Algomira is founder-led and works with a trusted network of experienced, independent data scientists to deliver statistical analysis, predictive modeling, anomaly detection, data visualization, workflow automation, and machine-learning solutions across life sciences and selected cross-industry applications.
Where we focus
- Disease modeling
- EHR and real-world data analytics
- Statistical and quantitative analysis
- Biomedical data integration
What you receive
- Data analysis and interpretation
- Decision-support frameworks
- Evidence-based hypotheses
- Scientific recommendations
Reduce uncertainty
Scientific Strategy & Research Support
Evaluate scientific readiness, identify technical risks, and strengthen the evidence behind development, investment, funding, and partnership decisions.
Where we focus
- Scientific and technical due diligence
- Technology and platform assessment
- Competitive landscape analysis
- CRO and external partner selection
- Grant and non-dilutive funding strategy
- Scientific communications
What you receive
- Risk and opportunity assessment
- Go/no-go decision framework
- Scientific landscape report
- Grant or technical narrative support
A focused first step
Bring us your hardest preclinical decision.
We’ll help clarify the question, identify the evidence gap, and define a practical path forward.
Start a conversation